Biotech bags cash for targeted delivery of cancer drugs
To view this email as a web page, click here

Today's Rundown

Featured Story

BARDA, in 'Beyond the Needle' DRIVe, backs IDRI to develop nasal RNA vaccine against pandemic flu

The Infectious Disease Research Institute (IDRI) has secured U.S. government support for its nasal RNA vaccine project. BARDA is putting up the money, positioning the nonprofit IDRI to use a nanostructured lipid carrier delivery system to deliver self-amplifying RNA via the nose.

read more

Top Stories

Candel enlists Bionauts for fight against brain cancers, setting stage for delivery of oncolytic viruses using tiny robots

Bionaut Labs and Candel Therapeutics have teamed up for a fantastic voyage. The newly minted partners plan to use Bionaut’s remote-controlled robots to deliver novel oncolytic viral immunotherapies to brain tumors.

read more

Turkish biotech bags $12M for targeted delivery of cancer drugs

Turkey’s biotech scene has a new star: RS Research. The startup has reeled in $12 million in series A cash to fund development of candidates based on a targeted delivery system for chemotherapeutic agents. 

read more

Iacta bags rights to Tallc's pan-ocular drug delivery technology

Iacta Pharmaceuticals’ hunt for technologies that improve the delivery of drugs to the eye has led it to Tallc, developer of a micellar technology for pan-ocular drug delivery.

read more

Fierce Biotech’s top 10 data readouts in 2022

There are a number of potential blockbuster drugs on the list, but it’s not all about revenue potential. Many of the compounds are high-risk, high-reward candidates trying to push the boundaries of drug treatment.

read more

Resources

Research: How Buffer Prep Services Alleviate Sudden Spikes in Campaign Volume

Learn how a CDMO partnered with Thermo Fisher Scientific to manage high-volume process liquid and buffer preparation scale-up. Download the free case study from Thermo Fisher Scientific

Whitepaper: Patients Want Choice Offered through Hybrid Clinical Trials

New survey results and insights help clinical trial sponsors improve diversity and inclusion, enroll faster, and keep participants engaged longer.

Whitepaper: Tailored, Dedicated Support Expedites COVID-19 Vaccine Trial

Sites receiving augmentation support enroll more than 30,000 patients in just over three months. See how additional site resources can make a difference.

Whitepaper: QC for ex vivo manipulated cell lines and tissues

A variety of genetic analysis methods are valuable in ensuring that ex vivo human cells to be used for cell-based therapies are correctly identified, have the correct characteristics, and are free of contaminants.

Whitepaper: Modernizing Key Clinical Trial Processes with Artificial Intelligence

This whitepaper addresses where AI can make the biggest impact in clinical trials. The stakes are too high for patients to leave decision-making to machines, but AI can lend administrative support that empowers staff and medical experts alike to carry out their jobs more effectively.

Whitepaper: QC for ex vivo manipulated cell lines and tissues

A variety of genetic analysis methods are valuable in ensuring that ex vivo human cells to be used for cell-based therapies are correctly identified, have the correct characteristics, and are free of contaminants.

Whitepaper: Medable was able to cut costs in multiple clinical trials by over US$25,000,000

Find out how to improve clinical protocol adherence, and thus patient outcomes, by 15%+ with Medable’s latest White Paper.

Webinar: Using Next Best to Elevate your Omnichannel Marketing Strategy

Learn how to elevate your omnichannel marketing strategy with Next Best - a combination of data and analytics, deployed to facilitate decision making.

Whitepaper: Healthcare Technical Due Diligence: Assessing a New Cancer Treatment

A major Korean biopharmaceutical company wanted to gather unbiased opinions on a new cancer treatment product. Fill out our form to learn more.

Whitepaper: Demand Planning for New Drug/Device Combination

Download now to learn how GLG helped a biotech company plan for the demand of a new drug/device combination by commissioning a forecasting study.

Webinar: The Faster Path From Pre-Filled Syringe to Auto-Injector

Ypsomed and Catalent Biologics experts discuss strategies for integrated PFS manufacturing and auto-injector assembly to accelerate timelines and more in this webinar.

Whitepaper: Formulation Strategies When Transitioning From Vial to PFS

Learn how formulation development for a PFS affects manufacturing to drive the industry toward optimizing delivery of injectable products and, ultimately, improving patient care.

Whitepaper: Enhance the cost-effectiveness of your cGMP chemical supply chain

Learn how to develop a high-performing supply chain for cGMP chemicals used throughout your biologics workflow. Download the free whitepaper from Thermo Fisher Scientific

eBook: Get solutions to market faster

Read Get to Know Cloud Content Management for Life Sciences and learn how to eliminate silos across all workflows, from R&D to commercialization.

Events